Treatment of hyperkalemia with salbutamol and insulin

Pakistan Journal of Medical Sciences

Volumn 22, Issue 2, 2006, Pages 176-179

  Mushtaq, Muhammad Amer ^a,c   Masood, Muhammad ^b  

^a FATIMA MEMORIAL HOSPITAL   (Pakistan)

^b SERVICES HOSPITAL   (Pakistan)

^c 121/B 32/S Hameed Park ^*  (Pakistan)

Author keywords

Hyperkalemia; Insulin; Salbutamol

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM; SALBUTAMOL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BOLUS INJECTION; BREATHING RATE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERKALEMIA; HYPOKALEMIA; MALE; POTASSIUM BLOOD LEVEL; PULSE RATE;

EID: 33744486902     PISSN: 1682024X     EISSN: 1682024X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Spital A, Freedman Z. Severe hypercalcemia in woman with renal failure. Am J Kidney Dis 1995; 26:674-7.
2. Greenberg A. Hyperkalemia: treatment options. Semin Nephrol 1998; 1:46-57.
3. Alkhunaizi AM, Schrier RW. Management of acute renal failure: New perspectives. Am J Kidney Dis 1996; 28:315-28.
4. Allon M. Treatment and prevention of hyperkalemia in end stage renal disease. Kidney Int 1993; 43:1197-1209.
5. Iqbal S, Javed SH, Khan JH, Akbar A, Khan FA. Pattern of renal failure disease at Lahore general hospital.Pak Post Graduate Med Journal 1993;4(2):107-16.
6. Defronzo RA, Smith JD. Clinical disorders of hyperkalemia. In: Narins RG (ed): Clinical disorders of fluid and electrolyte metabolism. New York, NY, MacGraw-Hill 1994; 697-754.
7. Liou HH, chiang SS, Wu SC, Huang TP, Campese VM, Smogorzewski M, et, al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis 1994; 23:266-71.
8. Mehta RL. Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin Nephrol 1994; 14:64-82.
9. Rahman SN, Kim GE, Mathew AS, Goldberg CA, Allgren R, Schrier RW, Conger JD. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994; 45: 1731-38.
10. Allon M, Shanklin N. Effect of albuterol treatment on subsequent dialytic potassium removal. Am J Kidney Dis 1995; 26:607-13.
11. Kokko JP. Disorders of fluid, volume, electrolytes and acid base balance. In: Bennet JC, Plum F eds. Cecil text book of medicine. Philadelphia: WB Saunders 1996; 20th ed: 525-51.
12. Taylor DR, Wilkins GT, Herbison GP, Flannery MB. Interaction between corticosteroid and beta agonist drugs: Biochemical and cardiovascular effects in normal subjects. Chest 1992; 102:519-24.
13. Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interaction with insulin and albuterol. Am J Kid Dis 1996; 28:508-14.
14. Lens XM, Montoliu J, Cases A, Campistol JM, Revert L. Treatment of hyperkalemia in renal failure: salbutamol v insulin. Nephrol Dial Transplant 1989; 4:228-32.
15. Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990; 38:869-72.